Evaluation of a Generic Bortezomib Molecule in Newly Diagnosed Multiple Myeloma Patients

Objective: Constantly increasing health expenditures lead use of generic molecules and generics of bortezomib have been used for a long time. The aim of this study is to retrospectively examine the effectiveness, side effects and reliability of generic bortezomib in newly diagnosed multiple myeloma...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Sinan Mersin, Ayfer Gedük, Özgür Mehtap, Pınar Tarkun, Serkan Ünal, Merve Gökçen Polat, Kemal Aygün, Emel Merve Yenihayat, Hayrunnisa Albayrak, Abdullah Hacıhanefioğlu
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Turkish Society of Hematology 2021-08-01
Edice:	Turkish Journal of Hematology
Témata:	bortezomib multiple myeloma equivalent
On-line přístup:	https://jag.journalagent.com/z4/download_fulltext.asp?pdir=tjh&un=TJH-56750
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!